COGNICURRENT

Neuza Frazzati has developed Brazil's first single-dose vaccine against dengue, addressing a public health crisis that has claimed thousands of lives.

The dengue vaccine developed by the Butantan Institute continues to show 80.5% efficacy against severe cases of dengue after five years of study.

The article covers various criminal cases and political events in Brazil, including an ongoing investigation into allegations of corruption and a discussion regarding the dengue vaccine's efficacy.

A long-term analysis of the dengue vaccine developed by Butantan reveals that one dose provides at least five years of protection and significantly reduces severe disease cases.

Mato Grosso do Sul has received nearly 8,000 doses of the dengue vaccine, targeting health professionals first in a nationwide immunization strategy.

Salvador, Brazil, has commenced its dengue vaccination campaign using a locally produced vaccine targeting healthcare workers and other professionals in the community.

The dengue vaccination campaign has started in Uberlândia, Brazil, targeting healthcare workers involved in disease prevention and control.

The Brazilian-made dengue vaccine has started being distributed in Bahia, initially targeting health professionals aged 15 to 59 who have not received other dengue vaccines.

Sergipe has received 7,900 doses of a dengue vaccine produced by the Butantan Institute, aimed initially at health professionals.

Rio de Janeiro has started administering a new dengue vaccine, developed by the Butantan Institute, exclusively to frontline healthcare workers.

The São Paulo government has expedited the delivery of 1.3 million doses of the dengue vaccine from the Butantan Institute to the Ministry of Health, as announced by Governor Tarcísio de Freitas.

The São Paulo government has announced the delivery of an additional 1.3 million doses of the dengue vaccine and the establishment of a new hub for immunobiologicals.

The first batch of the dengue vaccine has arrived in Piauí, Brazil, to immunize around 32,200 healthcare workers.

The city of Bauru has lost doses of the dengue vaccine due to temperature fluctuations during storage.

São José dos Campos has begun administering the single-dose dengue vaccine to health professionals as part of a phased immunization strategy.

The new dengue vaccine developed by Butantan Institute is now being administered to healthcare professionals in Campinas, Brazil, starting with certain health agents.

Mogi das Cruzes has received over 4,137 doses of the Butantan-DV vaccine, the world's first single-dose vaccine against dengue, aimed at protecting local health professionals.

The city of Jacareí in Brazil begins a vaccination campaign against dengue, utilizing a single-dose vaccine amid confirmed cases and a death in the current year.

President Lula announced funding for the Butantan Institute and began a vaccination campaign against dengue using a new Brazilian vaccine.

Vaccination coverage against dengue in the Ribeirão Preto region remains below ideal levels, with only 27% of children and adolescents fully immunized.

The Cook Islands has reported a death linked to a dengue fever outbreak, prompting calls for vaccine availability in New Zealand and the launch of a national prevention campaign.

Piracicaba has commenced its dengue vaccination campaign with the Butantan-DV vaccine, initially targeting primary healthcare professionals starting Monday, September 9.

The government of São Paulo begins a vaccination campaign against dengue with the Butantan-DV vaccine on Monday, encompassing all 645 municipalities in the state.

Children and adolescents aged 10 to 14 in Paraíba will begin receiving the dengue vaccine across all 223 municipalities, starting Monday, with the first dose being administered.